Serum adropin is unaltered in adolescents with histology‐confirmed steatotic liver disease

Ähnliche Einträge

• Oxidized high‐density lipoprotein and low‐density lipoprotein in adolescents with obesity and metabolic dysfunction‐associated steatotic liver disease
  von: Alyssa M. Bartlett, et al.
  Veröffentlicht: (2024)
• Fibrosis and steatotic liver disease in US adolescents according to the new nomenclature
  von: Ning Ma, et al.
  Veröffentlicht: (2024)
• The prevalence and predictors of metabolic dysfunction‐associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults
  von: Brandon J. Perumpail, et al.
  Veröffentlicht: (2024)
• Pharmacological management of pediatric metabolic dysfunction‐associated steatotic liver disease
  von: Rasha Abi Radi Abou Jaoudeh, et al.
  Veröffentlicht: (2024)
• Glucagon‐like peptide‐1 receptor agonists in pediatric metabolic dysfunction‐associated steatotic liver disease
  von: Andrea M. Tou, et al.
  Veröffentlicht: (2025)